Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.43
Delayed Data
As of 3:47pm ET
 -0.0099 / -0.41%
Today’s Change
2.00
Today|||52-Week Range
5.18
+1.25%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close2.44
Today’s open2.44
Day’s range2.43 - 2.46
Volume24,282
Average volume (3 months)90,246
Market cap$31.1M
Data as of 3:47pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)+66.73%
Earnings growth (this year)+30.65%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+3.70%
P/E ratioNM
Price/Sales0.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc+0.25+2.67%
CDMOPAvid Bioservices Inc-0.01-0.05%
TCONTRACON Pharmaceutica...-0.15-5.17%
AMPEAmpio Pharmaceutical...-0.08-4.60%
Data as of 8:00pm ET, 06/21/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$146.1M
Annual profit (last year)-$77.1M
Net profit margin-52.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
Senior VP, Chief Financial &
Business Officer
Angus W. Smith
Corporate headquarters
Morristown, New Jersey

Forecasts